Federated Hermes
NAUT icon

Federated Hermes’s Nautilus Biotechnolgy NAUT Stock Holding History

Federated Hermes’s Portfolio NAUT Stock Details NAUT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-9,500
Closed -$28.4K – 2102
2023
Q4 		$28.4K Buy
9,500
+367
+4% +$1.05K ﹤0.01% 1713
2023
Q3 		$28.9K Buy
+9,133
New +$29.7K ﹤0.01% 1735
2021
Q4 		– Sell
-800,000
Closed -$4.91M – 2266
2021
Q3 		$4.91M Hold
800,000
– – 0.01% 829
2021
Q2 		$8.08M Hold
800,000
– – 0.02% 718
2021
Q1 		$11M Hold
800,000
– – 0.02% 637
2020
Q4 		$8.68M Hold
800,000
– – 0.02% 680
2020
Q3 		$8.58M Buy
+800,000
New +$8.53M 0.02% 603

Other funds holding NAUT

ACM
AH Capital Management Menlo Park, California $14.2B AUM 20.01% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
CM
Cercano Management Bellevue, Washington $750M AUM 25.77% 1-Year Est. Return
MVG
Madrona Venture Group Seattle, Washington $22.1M AUM 86.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CFM
Comprehensive Financial Management Los Gatos, California $3.05B AUM 1.77% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
ACI
Amazon.com Inc Seattle, Washington $4.42B AUM 22.6% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Federated Hermes's NAUT Position: Q1 2024 in Review

Federated Hermes sold out of Nautilus Biotechnolgy (NAUT) in Q1 2024, closing a stake of 9,500 shares — an estimated $28.4K sold.

Federated Hermes first reported a position in NAUT in Q3 2020 and held it in 7 quarters. The position peaked at $11M in Q1 2021. 73 funds tracked by Wall St. Rank hold NAUT as of Q1 2024.

  • Federated Hermes reported no remaining Nautilus Biotechnolgy position as of Q1 2024 after selling out during the quarter.
  • Federated Hermes sold 9,500 Nautilus Biotechnolgy shares in Q1 2024, an estimated $28.4K.
  • Federated Hermes first reported a position in Nautilus Biotechnolgy in Q3 2020 and held it in 7 quarters.
  • Federated Hermes's Nautilus Biotechnolgy position peaked at $11M in Q1 2021.
  • 73 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q1 2024.

Based on Federated Hermes's 13F filing for Q1 2024, filed 14 May 2024.